The three-noes right-sided infective endocarditis: An unrecognized type of right-sided endocarditis.


Journal

Medicine
ISSN: 1536-5964
Titre abrégé: Medicine (Baltimore)
Pays: United States
ID NLM: 2985248R

Informations de publication

Date de publication:
21 Jul 2023
Historique:
medline: 24 7 2023
pubmed: 21 7 2023
entrez: 21 7 2023
Statut: ppublish

Résumé

The "3 noes right-sided infective endocarditis" (3no-RSIE: no left-sided, no drug users, no cardiac devices) was first described more than a decade ago. We describe the largest series to date to characterize its clinical, microbiological, echocardiographic and prognostic profile. Eight tertiary centers with surgical facilities participated in the study. Patients with right-sided endocarditis without left sided involvement, absence of drug use history and no intracardiac electronic devices were retrospectively included in a multipurpose database. A total of 53 variables were analyzed in every patient. We performed a univariate analysis of in-hospital mortality to determine variables associated with worse prognosis. the study was comprised of 100 patients (mean age 54.1 ± 20 years, 65% male) with definite 3no-RSIE were included (selected from a total of 598 patients with RSIE of all the series, which entails a 16.7% of 3no-RSIE). Most of the episodes were community-acquired (72%), congenital cardiopathies were frequent (32% of the group of patients with previous known predisposing heart disease) and fever was the main manifestation at admission (85%). The microbiological profile was led by Staphylococci spp (52%). Vegetations were detected in 94% of the patients. Global in-hospital mortality was 19% (5.7% in patients operated and 26% in patients who received only medical treatment, P < .001). Non-community acquired infection, diabetes mellitus, right heart failure, septic shock and acute renal failure were more common in patients who died. the clinical profile of 3no-RSIE is closer to other types of RSIE than to LSIE, but mortality is higher than that reported on for other types of RSIE. Surgery may play an important role in improving outcome.

Identifiants

pubmed: 37478259
doi: 10.1097/MD.0000000000034322
pii: 00005792-202307210-00054
pmc: PMC10662813
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e34322

Informations de copyright

Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc.

Références

Rev Esp Cardiol. 2008 Dec;61(12):1253-9
pubmed: 19080963
BMC Infect Dis. 2018 Feb 21;18(1):85
pubmed: 29466956
J Am Coll Cardiol. 2017 Jan 3;69(1):111-112
pubmed: 28057237
Cardiol Clin. 2003 May;21(2):167-84, v-vi
pubmed: 12874891
Eur Heart J. 2007 Jan;28(1):65-71
pubmed: 17032690
Eur Heart J. 2019 Oct 14;40(39):3222-3232
pubmed: 31504413
Presse Med. 2019 May;48(5):532-538
pubmed: 31056233
Postgrad Med J. 1993 Aug;69(814):615-20
pubmed: 8234104
Ann Intern Med. 2009 May 5;150(9):586-94
pubmed: 19414837
Eur Heart J. 2015 Nov 21;36(44):3075-3128
pubmed: 26320109
Am J Med Sci. 1997 Sep;314(3):207-12
pubmed: 9298048
Medicine (Baltimore). 2014 Dec;93(27):e137
pubmed: 25501052
Eur Heart J. 2013 Jul;34(26):1999-2006
pubmed: 23060453
Heart Lung Circ. 2020 Jun;29(6):840-850
pubmed: 31402124

Auteurs

Gonzalo Cabezón (G)

Hospital Clínico Universitario, CIBERCV, Valladolid, Spain.

Javier López (J)

Hospital Clínico Universitario, CIBERCV, Valladolid, Spain.

Isidre Vilacosta (I)

Hospital Clínico Universitario San Carlos, Madrid, Spain.

Gilbert Habib (G)

APHM, La Timone Hospital, Cardiology Department, Marseille France.
Aix Marseille Univ, IRD, APHM, MEPHI, IHU-Méditerranée Infection, Marseille, France.

José María Miró (JM)

Hospital Clinic-IDIBAPS, University of Barcelona, Barcelona, Spain.
CIBERINFEC. Instituto de Salud Carlos III, Madrid, Spain.

Carmen Olmos (C)

Hospital Clínico Universitario San Carlos, Madrid, Spain.

Cristina Sarriá (C)

Hospital Universitario La Princesa, Madrid, Spain.

Marta Hernandez-Meneses (M)

Hospital Clinic-IDIBAPS, University of Barcelona, Barcelona, Spain.

Carlos González-Juanatey (C)

Hospital Universitario Lucus Augusti, Lugo, Spain.

José Ramón González-Juanatey (JR)

Hospital Clínico Universitario, CIBERCV, Santiago DE Compostela, Spain.
IDIS, Insituto de Investigación Sanitaria de Santiago de Compostela.

Jaume Llopis (J)

Hospital Clinic-IDIBAPS, University of Barcelona, Barcelona, Spain.
Department of Genetics, Microbiology and Statistics, University of Barcelona, Barcelona, Spain.

Guillermo Cuervo (G)

Hospital Universitario de Bellvitge, Barcelona, Spain.

Carmen Sáez (C)

Hospital Universitario La Princesa, Madrid, Spain.

Itziar Gómez (I)

Hospital Clínico Universitario, CIBERCV, Valladolid, Spain.

J Alberto San Román (JA)

Hospital Clínico Universitario, CIBERCV, Valladolid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH